Interleukin 1α (IL-1) and macrophage colony-stimulating factor (M-CSF) accelerate recovery from multiple drug-induced myelosuppression

Anticancer Research

Volumn 18, Issue 3 A, 1998, Pages 1805-1812

  Kovacs, Charles J ^a   Kerr, John A ^a   Daly, Barbara M ^a   Evans, Mark J ^a   Johnke, Roberta M ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Combinations selective chemosensitivity; Cytokines; Drug; Hematopoietic recovery

Indexed keywords

CISPLATIN; COLONY STIMULATING FACTOR 1; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; RECOMBINANT INTERLEUKIN 1ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG INDUCED DISEASE; FEMALE; GRANULOCYTE; HEMATOPOIETIC STEM CELL; INTRAPERITONEAL DRUG ADMINISTRATION; MAXIMUM PERMISSIBLE DOSE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW CELLS; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; GRANULOCYTES; HEMATOPOIETIC STEM CELLS; INTERLEUKIN-1; MACROPHAGE COLONY-STIMULATING FACTOR; MICE; MICE, INBRED C57BL;

EID: 0031829861     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Kovacs CJ, Harrell JP, Gooya JM, Evans MJ, Johnke RM: Synergy between recombinant human IL-1α (IL-1) and M-CSF (rHuM-CSF) during the recovery of murine hematopoietic activity in myelosuppressed animals: Abbreviated versus chronic administration of rHuM-CSF. Exp Hematol 20: 582-589, 1992.
2. Bradley TR, Williams N, Kriegler AB, Fawcett J, Hodgson GS: In vivo effects of interleukin-1 on regenerating mouse bone marrow myeloid colony-forming cells after treatment with 5-fluorouracil. Leukemia 3: 893-898, 1989.
3. Moore MAS, Warren DJ: Synergy of interleukin 1 and granulocyte colony-stimulating factor: In vivo stimulation of stem cell recovery and hematopoietic regeneration following 5-flourouracil treatment of mice. Proc Natl Acad Sci USA 84: 7134-7139, 1987.
4. Hodgson GS, Bradley TR, Radley JM: The organization of hematopoietic tissue as inferred from the effects of 5-fluorouracil. Exp Hematol 10: 26-35, 1992.
5. Bradley TR, Hodgson GS, Bertoncello I: Characteristics of primitive macrophage progenitor cells with high proliferative potential: relationship to cells with marrow repopulating ability in 5-fluorouracil treated mouse bone marrow. In: Baum SJ, Ledney GD, van Bekkum DW. Experimental Hematology Today - 1980, New York, S. Karger, 285-297, 1980.
6. McNiece IK, Bertoncello I, Briegler AB, Quesenberry PJ: Colony-forming cells with high proliferative potential (HPP-CFC). Int J Cell Clon 8: 1446-1450, 1990.
7. Bartelmez SH, Bradley TR, Bertoncello I, Mochizuki DY, Tushinski RJ, Stanley R: Interleukin 1 plus interleukin 3 plus colony-stimulating factory 1 are essential for clonal proliferation of primitive myeloid bone marrow cells. Exp Hematol 17: 240-245, 1989.
8. McNiece IK: Synergism of hematopoietic colony-stimulating factors. Am J Pediatr Hematol Oncol 14: 31-38, 1992.
9. Kovacs CJ, Harrell JP, Evans MJ, Abernathy RS, Roberts CJ, Johnke RM: Stem cell responses in myelosuppressed mice following sequential treatment with recombinant human interleukin 1 (rHuIL-1), recombinant murine interleukin 3 (rMuIL-3) and recombinant human macrophage colony-stimulating factor (rHuM-CSF). Stem Cells 12: 103-113, 1994.
10. Kovacs CJ, Evans MJ, Roberts C, Harrell J, Abernathy R, Gooya J, Johnke RM: Temporal recovery of short-term repopulating HSC subpopulations in marrow following schedule-dependent administrations of IL-1α and M-CSF. Exp Hematol 23: 1016-1023, 1995.
11. Kovacs CJ, Powell DS, Evans MJ, Thomas-Patterson D, Johnke RM: Enhanced platelet recovery in myelosuppressed mice treated with interleukin 1 (IL-1α) + macrophage colony-stimulating factor (M-CSF). Potential interactions with cytokines having megakaryocyte colony-stimulating activity. J Cytokine Lymphokine Res 16: 187-194, 1996.
12. Evans MJ, Kovacs CJ, Roberts CJ: Interleukin 1 (IL-1) and macrophage-colony stimulating factor (M-CSF) interact in vivo to prolong the expansion of cycling primitive stem cells in myelosuppressed marrow. Exp Hematol 20: 772, 1992.
13. Eppstein DA, Kurahara CG, Bruno NA, Terrell TG. Prevention of doxorubicin-induced hematotoxicity in mice by interleukin 1. Cancer Res 49: 3955-3960, 1989.
14. Fibbe WE, Van der Meer JWM, Falkenburg JHF, Hamilton MS, Kluin PM, Dinarello CA: A single low dose of human recombinant interleukin 1 accelerates the recovery of neutrophils in mice with cyclophosphamide-induced neutropenia. Exp Hematol 17: 805-809, 1989.
15. Evans MJ, Kovacs, CJ, Gooya JM, Harrell JP: Interleukin 1-a protects against the toxicity associated with combined radiation and drug therapy. Int J Radiat Oncol Biol Phys 26: 303-306, 1991.
16. Botnick LE, Hannon EC, Hellman S: Multisystem stem cell failure after apparent recovery from alkylating agents. Cancer Res 41: 1942-1947, 1978.
17. Kovacs CJ, Johnke RM, Emma DA, Scarantino CW: Effect of prolonged expansion of marrow progenitor compartments following doxorubicin (AdR) on subsequent radiation tolerance. Exp Hematol (Suppl 16): 89-94, 1985.
18. Fried W, Barone J: Residual marrow damage following therapy with cyclophosphamide. Exp Hematol 8: 610-614, 1980.
19. Slordal L, Warren DL, Moore MAS: Protective effects of tumor necrosis factor on hematopoiesis during cycle-specific cytotoxic chemotherapy. Cancer Res 50: 4216-4220., 1990.
20. Gringeri A, Keng PC, Borch RF: Diethyldithiocarbamate inhibition of murine bone marrow toxicity caused by as diamminedichloroplatinum (II) or diammine-(1, lcyclobutanedi-carboxy-late) platinum (II). Cancer Res 46: 5708-5712, 1988.
21. Evans RG, Wheatley C, Engel C, Nielsen J, Ciborowski LJ: Modification of the bone marrow toxicity of cis-diamminedichloroplatinum (II) in mice by diethyldithiocarbamate. Cancer Res 44: 3686-3690, 1984.
22. Schmalbach TK, Borch RF: Myeloprotective effect of diethyldithiocarbamate treatment follow-ing 1 ,3-bis(2-chloroethyl)-1-nitrosourea, adriamycin, or mitomycin C in mice. Cancer Res 49: 2574-2577, 1989.
23. Kalechman Y, Sotnik-Barkai I, Albeck M, Sredni B: Protection of bone marrow cells from the toxic effects of cytclophosphamide in vivo and of ASTA-Z 7557 and etoposide in vitro by ammonium trichloro(dioxyetheylene-o-o') tellurate (AS101). Cancer Res 53: 1838-1844, 1993.
24. de Jong JP, Nikkels PGJ, Brockbank KGM, Ploemacher RE, Voerman SA: Comparative in vitro effects of cyclophosphamide derivatives on murine bone marrow-derived stromal and hemopoietic proge nitor cell classes. Cancer Res 45: 4001-4005, 1985.
25. Nowrousian MR, Schmidt CG: Effects of cis-platin on different hemopoietic progenitor cells in mice. Brit J Cancer 46: 397-402, 1982.
26. Boggs SS, Chervenick pA, Boggs DR: The effect of postirradiation bleeding or endotoxin on the proliferation and differentiation of hematopoietic stem cells. Blood 40: 375-389, 1972.
27. Botnick LE, Hannon EC, Vigneulle R, Hellman S: Differential effects of cytotoxic agents on hematopoietic progenitors. Cancer Res 41: 2338-2342, 1981.
28. Kovacs CJ, Evans MJ, Daly BM, Thomas-Patterson D, Johnke RM, Powell DS: Secondary cytokines interact in sequence with interleukin 1α (IL-1α) with or without macrophage colony-stimulating factor (M-CSF) to further accelerate granulopoietic recovery in myelosuppressed mice. J Interferon Cytokine Res 17: 453-460, 1997.
29. 13 in vitro. In: Cronkite EP, Daniak N, McCaffrey RP, Palek J, Quesenberry PJ. Hematopoietic Stem Cell Physiology, Alan R. Liss, Inc., New York 39-56, 1985.
30. Hestdal K, Ruscetti FW, Chizzonite R, Ortiz M, Gooya JM, Longo DL, Keller JR: Interleukin-1 (IL-1) directly and indirectly promotes hematopoietic cell growth through type I IL-1 receptor. Blood 84: 125-132, 1995.
31. Lee M, Gegal GM, Bagby GC: Interleukin 1 induces human bone marrow-derived fibroblasts to produce multilineage hematopoietic growth factors. Exp Hematol 84: 7134-7138, 1990.
32. Fibbe WE, van Damme D, Billiau A, Goselink HM Voogt PJ, van Eden RP, Altrock BW, Falkenburg JHF. Interleukin-1 induces human marrow stromal cells in long-term culture to produce granulocyte-colony-stimulating factor and macrophage colony-stimulating factor. Blood 71: 430-437, 1988.
33. Harrell JP, Kovacs CJ, Johnke RM, Evans MJ: Interleukin 1 (IL-1) stimulation of hematopoiesis in normal and myelosuppressed bone marrow cells supported by irradiated, adherent stromal cells. Exp Hematol 20: 774, 1992.
34. Nikkels PGJ, De Jond, JP: Effects of cis-diamminedichloroplatinum (II) upon haemopoietic progenitors and the haemopoietic micro-environmnet in mice. Brit J Hematol 68: 3-9, 1988.